Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation
Authors:
Open Access
- 1 February 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 40, 92-105
Abstract
No abstract availableKeywords
Funding Information
- Program of China (2015CB553903)
- National Science-technology Supporting Plan Projects (2015BAI13B05)
- National Natural Science Foundation of China (81702573, 81772787, 81402159, 81472783, 81372806, 81372801, 81572570)
- National Science and Technology Major Sub-Project (2018ZX10301402-002)
- Technical Innovation Special Project of Hubei Province (2018ACA138)
This publication has 53 references indexed in Scilit:
- Mitochondrial Complex III Deficiency Caused by a HomozygousUQCRC2Mutation Presenting with Neonatal-Onset Recurrent Metabolic DecompensationHuman Mutation, 2013
- A Census of Human Soluble Protein ComplexesCell, 2012
- Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathwayProceedings of the National Academy of Sciences, 2010
- Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen SensingJournal of Biological Chemistry, 2010
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- The mitochondrial p53 pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigenBMC Cancer, 2009
- Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sitesBiochemical Journal, 2006
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001